Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effects of JFET Region Design and Gate Oxide Thickness on the Static and Dynamic Performance of 650 V SiC Planar Power MOSFETs

Autor: Shengnan Zhu, Tianshi Liu, Junchong Fan, Hema Lata Rao Maddi, Marvin H. White, Anant K. Agarwal

Publikováno v: Materials; Volume 15; Issue 17; Pages: 5995

650 V SiC planar MOSFETs with various JFET widths, JFET doping concentrations, and gate oxide thicknesses were fabricated by a commercial SiC foundry on two six-inch SiC epitaxial wafers. An orthogonal P+ layout was used for the 650 V SiC MOSFETs to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2698cf26d8411e6337f84b47b3f52b5b
https://doi.org/10.3390/ma15175995

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials

Autor: Giuseppe M.C. Rosano, John Kjekshus, Karina V Bunting, Andrew J.S. Coats, Alan S. Rigby, John J.V. McMurray, John Wikstrand, John G.F. Cleland, Bert Andersson, Douglas G. Altman, Dipak Kotecha, Michael Böhm, Frank Ruschitzka, Hans Wedel, Marcus Flather, Dirk J. van Veldhuisen, Luis Manzano, Thomas G. von Lueder, Jane Holmes, Milton Packer, Åke Hjalmarson

Publikováno v: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
European Heart Journal, 39(1), 26-35. Oxford University Press

Aims Recent guidelines recommend that patients with heart failure and left ventricular ejection fraction (LVEF) 40–49% should be managed similar to LVEF ≥ 50%. We investigated the effect of beta-blockers according to LVEF in double-blind, randomi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d0e9c47973be816c30262e533f467ca
https://doi.org/10.1093/eurheartj/ehx564

Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction

Autor: Takamasa Iwai, Shogo Oishi, Tetsuo Yamaguchi, Takahiro Okumura, Takeshi Kitai, Ryoichi Miyazaki, Yuya Matsue, Takamichi Miyamoto, Sadahiro Hijikata, Keisuke Kida, Junji Yamaguchi, Satoshi Suzuki, Toshihiro Nozato, Masayoshi Yamamoto, Yasutoshi Nagata, Nobuhiro Hara, Ryo Masuda, Nobuyuki Kagiyama, Eiichi Akiyama

Publikováno v: American Journal of Cardiology, 121(8), 969-974. EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC

Guideline-directed medical therapy (GDMT) is recommended for patients with heart failure with reduced ejection fraction (HFrEF). However, the prognostic impact of medication optimization at the time of discharge in patients hospitalized with heart fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3d773c84189f92b5372162d1c1dcdc0
https://research.rug.nl/en/publications/9f2a8a6c-f936-4ecf-8063-86913528cdf2